Sumitomo Pharma Co., Ltd. (FRA:DPM)

Germany · Delayed Price · Currency is EUR

13.70

-4.80 (-25.95%)

Last updated: Feb 20, 2026, 3:51 PM CET

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals - Japan	99.84B	114.66B	126.16B	149.98B	152.57B
Pharmaceuticals - Japan Growth	-12.92%	-9.12%	-15.88%	-1.70%	9.17%
Pharmaceuticals - Asia	47.18B	40.86B	-	-	-
Pharmaceuticals - Asia Growth	15.46%	-	-	-	-
Pharmaceuticals - North America	251.81B	159.04B	328.47B	319.79B	281.49B
Pharmaceuticals - North America Growth	58.34%	-51.58%	2.71%	13.60%	7.32%
Pharmaceuticals - China	-	-	39.40B	38.30B	27.83B
Pharmaceuticals - China Growth	-	-	2.87%	37.60%	-2.71%
Pharmaceuticals - Other Overseas	-	-	16.75B	12.18B	17.23B
Pharmaceuticals - Other Overseas Growth	-	-	37.58%	-29.34%	16.55%
Other Business	-	-	44.88B	39.90B	36.94B
Other Business Growth	-	-	12.50%	8.00%	-1.28%
Elimination of Intersegment Transactions	-	-	-120.00M	-101.00M	-116.00M
Total	398.83B	314.56B	555.54B	560.04B	515.95B
Total Growth	26.79%	-43.38%	-0.80%	8.54%	6.88%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	92.59B	107.34B	170.61B	222.88B	192.61B
Japan Growth	-13.74%	-37.08%	-23.45%	15.72%	6.60%
North America (Excl. United States)	2.46B	2.63B	3.20B	4.77B	4.84B
North America (Excl. United States) Growth	-6.39%	-17.92%	-32.82%	-1.55%	-6.92%
United States of America	243.55B	152.55B	325.89B	282.52B	275.59B
United States of America Growth	59.65%	-53.19%	15.35%	2.51%	7.47%
Others (Excl. China)	18.48B	18.24B	-	-	-
Others (Excl. China) Growth	1.33%	-	-	-	-
China	41.75B	33.80B	-	-	-
China Growth	23.55%	-	-	-	-
Others	-	-	55.84B	49.86B	42.91B
Others Growth	-	-	12.00%	16.21%	6.14%
Total	398.83B	314.56B	555.54B	560.04B	515.95B
Total Growth	26.79%	-43.38%	-0.80%	8.54%	6.88%

Source: S&P Global Market Intelligence.